Difficulties in cryopyrin-associated periodic syndrome (CAPS) diagnosis in real practice (clinical case)
https://doi.org/10.33667/2078-5631-2025-28-15-20
Abstract
Introduction. Cryopyrin-associated periodic syndrome (CAPS) is an autoinflammatory disease that usually occurs in childhood and is characterized by episodes of unexplained fever combined with various organ lesions.
The aim is to analyze a clinical case of late diagnosis of cryopyrin-associated periodic syndrome that debuted in childhood. Materials and methods. A patient with a clinical picture of CAPS who repeatedly sought medical care at the outpatient level. An extended clinical, laboratory, and instrumental examination, including genetic analysis, was performed to conduct a differential diagnosis and verify the CAPS diagnosis.
Results. The clinical observation demonstrated that despite the classic debut of the disease in childhood with periodic fever and a burdened family history, the pediatrician did not have any concerns about the possible CAPS Subsequently, the progressive nature of the disease with severe skin manifestations, joint syndrome, eye damage, and sensorineural hearing loss were also neglected and did not considered as a reason for referring the patient to a rheumatologist. It was only when kidney damage and persistent inflammatory changes in the blood were detected that the possibility of a systemic rheumatic disease was suspected. The diagnosis of CAPS was established by a rheumatologist at in-patient clinic and confirmed by genetic test. The initiation of biological therapy with an interleukin‑1 inhibitor led to a rapid therapeutic effect.
Conclusions. Late diagnosis of orphan diseases remains an urgent problem in practical medicine. An adequate analysis of the clinical picture of the disease and family history is extremely important for the preliminary diagnosis of cryopyrin-associated periodic syndrome. The diagnosis is verified by genetic testing. Timely targeted therapy for CAPS is critical to prevent irreversible organ damage, primarily renal amyloidosis.
About the Authors
E. V. KalininaRussian Federation
Kalinina Elena V., PhD Med. Associate professor, associate professor at Dept of Faculty Therapy
Volgograd
I. V. Lekareva
Russian Federation
Lekareva Irina V., PhD Med. Associate professor, associate professor at Dept of Faculty Therapy
Volgograd
A. R. Babaeva
Russian Federation
Babaeva Aida R., DM Sci (habil.), professor, head of Dept of Faculty Therapy
Volgograd
References
1. Cryopyrin-associated periodic syndromes (Other specified disorders involving the immune mechanism, not classified elsewhere). Clinical guidelines of the Association of Pediatric Rheumatologists and the Association of Medical Geneticists, 2023. (In Russ.).
2. Rameev V.V., Lysenko L.V. (Kozlovskaya), Bogdanova M.V., Moiseev S.V. Autoinflammatory diseases. Clinical pharmacology and therapy. 2020; 29 (4); 49–60. (In Russ.).
3. Kozlova A.L., Mamzerova E.S., Novichkova G.A., Shcherbina A. Yu. Clinical manifestations and therapy of cryopyrin-associated periodic syndromes. Issues of hematology, oncology, and immunopathology in pediatrics. 2014; 13: 45–49. (In Russ.).
4. Zayaeva A.A., Shaduro D.V., Sokolova L.V., Petrov A.V., Teifukova E.N. Analysis of a clinical case of cryopyrin-associated periodic syndrome (CAPS). Difficult Patient. 2021; 19 (4): 55–59. (In Russ.).
5. Federici S, Sormani MP, Ozen S. et al. Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015 May; 74 (5): 799–805.
6. Gattorno M, Hofer M, Federici S. et al. Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO). Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019 Aug; 78 (8): 1025–1032.
7. Liu C., Zhang R., Yi C., Lin Y., Zhang H., Zhang C. Identification of an NLRP3 gene variant in a patient with Muckle-Wells syndrome: a case report and literature review. Pediatr Rheumatol Online J. 2023; 21 (1): 15.
8. Gupta A., Tripaty S. K., Phulvare R.H., Arawat S., Bagri N. K. Cryopyrin-associated periodic fever syndrome in children: a review of clinical cases. Int J Rheum Dis. 2020; 23 (2): 262–270.
9. Mohite RS, Kotecha U, Bhattacharya S. Familial cold autoinflammatory syndrome type 1. Indian J Pediatr. 2021; 88 (8): 834.
10. Salugina S. O., Fedorov E. S., Kuzmina N.N., Zakharova E. Yu. Interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS). Clinical experience. Modern Rheumatology. 2014; (4): 17–24. (In Russ.).
11. Welzel T., Kummerle-Deschner JB. Diagnosis and treatment of cryopyrin-associated periodic syndromes (CAPS): what we know so far. J Clin Med. 2021; 10 (1).
Review
For citations:
Kalinina E.V., Lekareva I.V., Babaeva A.R. Difficulties in cryopyrin-associated periodic syndrome (CAPS) diagnosis in real practice (clinical case). Medical alphabet. 2025;(28):15-20. (In Russ.) https://doi.org/10.33667/2078-5631-2025-28-15-20
JATS XML
























